Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 6.14
- Piotroski Score 3.00
- Grade Outperform
- Symbol (RGEN)
- Company Repligen Corporation
- Price $149.58
- Changes Percentage (7.2%)
- Change $10.07
- Day Low $145.00
- Day High $154.48
- Year High $211.13
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/12/2024
- Fiscal Year End N/A
- Average Stock Price Target $195.00
- High Stock Price Target $207.00
- Low Stock Price Target $155.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.27
- Trailing P/E Ratio 539.93
- Forward P/E Ratio 539.93
- P/E Growth 539.93
- Net Income $41.58 M
Income Statement
Quarterly
Annual
Latest News of RGEN
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
How To Be A Better Ally To Neurodivergent Colleagues
Neurodiversity encompasses various conditions like major depressive disorder and ADHD, affecting one in five American adults. While often overlooked, LinkedIn has a vibrant community of neurodivergent...
By Forbes | 9 hours ago -
Watch Decentralized AI In 2025: The Convergence Of AI And Crypto
In November, the dominating discussions besides the U.S. election are AI and crypto convergence. The surge began with a memecoin rise endorsed by an AI bot, sparking widespread interest....
By Forbes | 9 hours ago -
'Lack of respect': Argentina club start social media influencer in top-flight match
Deportivo Riestra, an Argentine football club, caused controversy by including a social media influencer with no football experience in their lineup for a top-flight match. The stunt was defended as a...
By The Guardian | 16 hours ago
